Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-01-25 @ 3:15 AM
Study NCT ID:
NCT05832827
Status:
RECRUITING
Last Update Posted:
2023-10-23
First Post:
2023-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas (Artemis)
Sponsor:
Organization: